Cancer Vaccine Institute News

The Cancer Vaccine Institute (CVI) is proud to highlight a recent JAMA Oncology  Viewpoint co‑authored by our Executive Director, Dr. Kiran Dhillon, and Dr. Lennard Lee of the University of Oxford, outlining why the time for cancer vaccines is now. For decades, the U.S. has invested in the science, infrastructure, and talent needed to make cancer vaccines possible. Early clinical data now show that these vaccines are safe, effective, and already providing meaningful benefits

The Cancer Vaccine Institute (CVI) took park in the 2025 San Antonio Breast Cancer Symposium from December 9-12, 2025, bringing our latest research to one of the world's leading forums for breast cancer science. Faculty members from the CVI presented four scientific posters with fellow collaborators, researchers, and scientists. Through these presentations, the CVI team highlighted recent discoveries in HER2-targeted vaccines, neoadjuvant immunotherapy, and findings from our

Every year, In Concert for Cancer brings people together through music, hope, and a shared commitment to ending cancer. At the Cancer Vaccine Institute (CVI), that commitment translates directly into momentum by fueling discoveries and supporting the people who will carry this mission forward. This year, their partnership is helping accelerate one of the most ambitious goals in cancer research: preventing ovarian cancer before it starts. And at the heart of that effort is a

Developing Vaccines to Create a New Standard of Care On October 22, 2025, the Cancer Vaccine Institute (CVI) at UW Medicine welcomed patients, advocates, researchers, and community members to DeLille Cellars in Woodinville, WA for an evening of connection and discovery. “Changing the Course of Ovarian Cancer” highlighted how cancer vaccines, once considered aspirational, are now changing lives and redefining what’s possible in cancer care. Driving a New Standard of Care The e